ClinicalTrials.gov
public full text
Public Domain
Low-dose S-ketamine in Women With Prenatal Depression
Prenatal depression is an important risk factor of postpartum depression. Low-dose ketamine has been used for depression treatment. As a stereoisomer of ketamine, s-ketamine has similar effects to ketamine in anti-depression. We speculate that, for pregnant women with prenatal depression, low-dose s-ketamine infusion after childbirth may reduce the incidence of postpartum depression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Esketamine on Postpartum Depression in Cesarean Section Women#868319
- Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study.#1146965
- Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study#1135358
- Postpartum Depression in the United States: A Systematic Review of Epidemiology, Risk Factors, and Contemporary Management With Emphasis on Emerging Therapeutic and Digital Care Models.#330661
- Prevalence and Risk Factors of Women Mental Health Disorders#826265
Record · ID 840453
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive